Cargando…

Shaping the future of pediatric liver health: unraveling the impact of the new metabolic-associated fatty liver disease definition

Detalles Bibliográficos
Autores principales:	Ciardullo, Stefano, Vergani, Michela, Ronchetti, Celeste, Perseghin, Gianluca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432300/ https://www.ncbi.nlm.nih.gov/pubmed/37600999 http://dx.doi.org/10.21037/hbsn-23-308

Ejemplares similares

Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Screening, Diagnosis, and Treatment
por: Ciardullo, Stefano, et al.
Publicado: (2023)

Impact of the new definition of metabolic dysfunction–associated fatty liver disease on detection of significant liver fibrosis in US adolescents
por: Ciardullo, Stefano, et al.
Publicado: (2022)

Nonalcoholic Fatty Liver Disease, Liver Fibrosis and Cardiovascular Disease in the Adult US Population
por: Ciardullo, Stefano, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease and risk of incident hypertension: a systematic review and meta-analysis
por: Ciardullo, Stefano, et al.
Publicado: (2021)

Lack of awareness of liver organ damage in patients with type 2 diabetes
por: Ciardullo, Stefano, et al.
Publicado: (2021)

Liver Stiffness, Albuminuria and Chronic Kidney Disease in Patients with NAFLD: A Systematic Review and Meta-Analysis
por: Ciardullo, Stefano, et al.
Publicado: (2022)

Blood pressure, glycemic status and advanced liver fibrosis assessed by transient elastography in the general United States population
por: Ciardullo, Stefano, et al.
Publicado: (2021)

What the New Definition of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Left Behind: Genetically Acquired Fatty Liver Disease (GAFLD)
por: Bril, Fernando
Publicado: (2021)

Prevalence of Elevated Liver Stiffness Among Potential Candidates for Bariatric Surgery in the United States
por: Ciardullo, Stefano, et al.
Publicado: (2022)

Soluble α-Klotho levels, glycemic control and renal function in US adults with type 2 diabetes
por: Ciardullo, Stefano, et al.
Publicado: (2022)

Serum neurofilament light chain levels are associated with all-cause mortality in the general US population
por: Ciardullo, Stefano, et al.
Publicado: (2023)

Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications
por: Ciardullo, Stefano, et al.
Publicado: (2020)

Unraveling the Paradox of Selective Insulin Resistance in the Liver: the Brain–Liver Connection
por: Ferris, Heather A., et al.
Publicado: (2016)

Update cognition of nonalcoholic fatty liver disease/metabolism‐associated fatty liver disease
por: Gu, Weijun, et al.
Publicado: (2022)

Pediatric non alcoholic fatty liver disease: more on novel treatment targets
por: Vajro, Pietro, et al.
Publicado: (2013)

Differential Association of Sex Hormones with Metabolic Parameters and Body Composition in Men and Women from the United States
por: Ciardullo, Stefano, et al.
Publicado: (2023)

Metabolic associated fatty liver disease and COVID-19: a double whammy?
por: Lin, Jaime Hui Xian, et al.
Publicado: (2020)

Fasting Whole-Body Energy Homeostasis and Hepatic Energy Metabolism in Nondiabetic Humans with Fatty Liver
por: Lattuada, Guido, et al.
Publicado: (2019)

Nonalcoholic Fatty Liver Disease Is Associated With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes
por: Bonapace, Stefano, et al.
Publicado: (2012)

Viewpoints on the Way to a Consensus Session: Where does insulin resistance start? The liver
por: Perseghin, Gianluca
Publicado: (2009)

Prolonged Use of Proton Pump Inhibitors and Risk of Type 2 Diabetes: Results From a Large Population-Based Nested Case-Control Study
por: Ciardullo, Stefano, et al.
Publicado: (2022)

Where does liver fat go? A possible molecular link between fatty liver and diabetes
por: Kikuchi, Akihiro, et al.
Publicado: (2016)

The Asia Pacific Pediatric Association (APPA) position statement on the MAFLD definition of fatty liver disease
por: Memon, Iqbal A., et al.
Publicado: (2023)

Challenges in the hepatic histopathology in non-alcoholic fatty liver disease
por: Brunt, Elizabeth M, et al.
Publicado: (2017)

What’s Past Is Prologue: History of Nonalcoholic Fatty Liver Disease
por: Targher, Giovanni
Publicado: (2020)

Adherence to antidiabetic drug therapy and reduction of fatal events in elderly frail patients
por: Rea, Federico, et al.
Publicado: (2023)

Assessing liver fibrosis in all patients with type 2 diabetes and fatty liver disease: It's time to act now
por: Lee, Chi Ho, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease: Definition and subtypes
por: Han, Seul Ki, et al.
Publicado: (2023)

Resting Whole Body Energy Metabolism in Class 3 Obesity; from Preserved Insulin Sensitivity to Overt Type 2 Diabetes
por: Manzoni, Giuseppina, et al.
Publicado: (2020)

Alterations of Central Liver Metabolism of Pediatric Patients with Non-Alcoholic Fatty Liver Disease
por: Berndt, Nikolaus, et al.
Publicado: (2022)

From the origin of NASH to the future of metabolic fatty liver disease
por: Geier, Andreas, et al.
Publicado: (2021)

Unraveling complexity of interconnected regulatory circuits in lipid metabolism
por: Yao, Zemin
Publicado: (2014)

Endoscopic Ultrasound-Guided Liver Biopsies: Is the Future Here Yet?
por: El Hajj, Ihab I., et al.
Publicado: (2019)

Unraveling Metabolic Dysfunction-Associated Fatty Liver Disease: Refining Sub-Phenotypes for Resolving Its Heterogeneity
por: Park, Jung Gil
Publicado: (2023)

A new noninvasive technique for estimating hepatic triglyceride: will liver biopsy become redundant in diagnosing non-alcoholic fatty liver disease?
por: Betzel, Bark, et al.
Publicado: (2014)

Urinary liver-type fatty acid binding protein and chronic kidney disease
por: Kamijo-Ikemori, A., et al.
Publicado: (2015)

NT-ProBNP and mortality across the spectrum of glucose tolerance in the general US population
por: Ciardullo, Stefano, et al.
Publicado: (2022)

miRNA-205: a future therapeutic molecule for liver diseases
por: Cabrera, Marco, et al.
Publicado: (2023)

Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome after Liver Transplant
por: Gitto, Stefano, et al.
Publicado: (2016)

Association of Metabolic Signatures with Nonalcoholic Fatty Liver Disease in Pediatric Population
por: Chae, Woori, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ni2nel1tl1c3188m8gffuhk3ea